Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

5.0K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
5.0K
Asepsis01:28

Asepsis

4.0K
The condition of being free from disease-causing living pathogens is asepsis. Aseptic techniques include a set of standard practices to achieve asepsis. An example is the regular environmental cleaning of all parts of the healthcare facility and hand hygiene at home before preparing or eating food. Medical and surgical asepsis in healthcare practice protects patients from harmful pathogens, minimizes the risk of contamination of susceptible sites, and reduces the risk of infection transmission.
4.0K
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

55
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
55

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mortality As a Measure of Treatment Effect in Clinical Trials Recruiting Critically Ill Patients.

Critical care medicine·2023
Same author

Impact of adherence to procalcitonin antibiotic prescribing guideline recommendations for low procalcitonin levels on antibiotic use.

BMC infectious diseases·2023
Same author

Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial.

JAMA·2022
Same author

Invited commentary on Sepsis.

Surgery·2022
Same author

Evaluation of Bebtelovimab for Treatment of Covid-19 During the SARS-CoV-2 Omicron Variant Era.

Open forum infectious diseases·2022
Same author

Proteomic changes associated with racial background and sepsis survival outcomes.

Molecular omics·2022
Same journal

Expert consensus on case definitions in human loiasis: a Delphi study.

The Lancet. Infectious diseases·2026
Same journal

The Bundibugyo virus disease outbreak: a warning signal for risks to health workers.

The Lancet. Infectious diseases·2026
Same journal

Trials of medical countermeasures to begin in DR Congo.

The Lancet. Infectious diseases·2026
Same journal

Community-based tuberculosis screening with computer-aided detection technology alone and in combination with point-of-care C-reactive protein testing: a paired screen-positive trial.

The Lancet. Infectious diseases·2026
Same journal

Context matters: WHO-recommended tools in combinations validated for community tuberculosis screening.

The Lancet. Infectious diseases·2026
Same journal

Global, regional, and national burden of tuberculosis and multidrug-resistant tuberculosis by HIV status, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.

The Lancet. Infectious diseases·2026
See all related articles

Related Experiment Video

Updated: Apr 13, 2026

A Data-Driven Approach to Quantifying Immune States in Sepsis
07:42

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

590

Sepsis: a roadmap for future research.

Jonathan Cohen1, Jean-Louis Vincent2, Neill K J Adhikari3

  • 1Brighton and Sussex Medical School, Brighton, UK.

The Lancet. Infectious Diseases
|May 2, 2015
PubMed
Summary
This summary is machine-generated.

Sepsis, a life-threatening condition, has high mortality despite improved care. New treatments are urgently needed as current research models struggle to advance sepsis management effectively.

More Related Videos

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
07:30

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

10.7K
A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
14:54

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis

Published on: January 27, 2019

12.0K

Related Experiment Videos

Last Updated: Apr 13, 2026

A Data-Driven Approach to Quantifying Immune States in Sepsis
07:42

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

590
Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
07:30

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

10.7K
A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
14:54

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis

Published on: January 27, 2019

12.0K

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Pathogenesis Research

Background:

  • Sepsis is a prevalent and fatal syndrome with persistently high mortality rates.
  • Current management relies on early recognition and supportive care, lacking specific anti-sepsis treatments.
  • Despite advances in understanding sepsis pathogenesis, therapeutic development has been unsuccessful.

Purpose of the Study:

  • To review the clinical epidemiology and current management of sepsis.
  • To identify limitations in existing research approaches for sepsis treatment development.
  • To propose a new roadmap for future sepsis research.

Main Methods:

  • Review of clinical epidemiology and management strategies for sepsis.
  • Analysis of challenges in developing novel sepsis therapies.
  • Formulation of recommendations for future research directions.

Main Results:

  • Mortality for sepsis remains high despite improved outcomes.
  • Existing clinical research models are unlikely to yield significant therapeutic advancements.
  • A critical re-evaluation of research approaches is necessary.

Conclusions:

  • Novel strategies are required to overcome the challenges in sepsis treatment development.
  • A new research roadmap is proposed to drive innovation in sepsis management.
  • Addressing the limitations in current research is crucial for improving patient outcomes.